Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

FMC vs NTR: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

NTR Captures Overall Composite Edge (52.1 HOLD vs 46.7 HOLD), While FMC Leads 4–2 on Growth & Valuation Pillars

NTR Overall Winner 6-Pillar Tally: FMC 4 – 2 NTR Matrix Metrics: FMC 2 – 8 NTR

As of Nov 17, 2026, Nutrien Ltd. Common Shares (NTR) captures the overall head-to-head institutional edge over FMC Corporation (FMC) on higher Unified Composite conviction (52.1/100 HOLD vs. 46.7/100 HOLD) after splitting the core matrix 8–2 (led by Growth & Scale, Profitability & Quality), while FMC wins 4–2 across the 6-pillar growth and valuation breakdown. FMC trades at $4.96 (5.5x Forward P/E, -15.7% operating margin) versus NTR at $69.31 (13.5x Forward P/E, 13.0% operating margin).

  • Growth vs. Quality Trade-Off: NTR earns the overall head-to-head edge with a stronger Unified Composite Score (52.1/100 HOLD vs. FMC 46.7/100 HOLD) and -0.28β · 24% Vol risk profile, whereas FMC leads top-line expansion (-80.5% YoY revenue growth, 0.46x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: FMC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.0); meanwhile NTR trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 45.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About FMC vs NTR
FMC NYSE
FMC Corporation
Chemicals & Allied Products
$4.96
-5.07% 1D
Market Cap $810.5M
TTM Revenue $2.81B
Forward P/E 5.5x
Beta / 30D Vol 0.21β · 132% Vol
Unified Composite Score
46.7 / 100 HOLD
Tech 33.0 Fund 53.0 Flow 67.0 Mom 74.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -23.5%), weak momentum, RSI 36
RSI-14: 36.0 · SMA20: $5.39 · SMA50: $7.64
NTR NYSE Head-to-Head Winner
Nutrien Ltd. Common Shares
Agricultural Chemicals
$69.31
+0.54% 1D
Market Cap $33.8B
TTM Revenue $27.4B
Forward P/E 13.5x
Beta / 30D Vol -0.28β · 24% Vol
Unified Composite Score
52.1 / 100 HOLD
Tech 49.0 Fund 55.0 Flow 59.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 45
RSI-14: 45.1 · SMA20: $70.19 · SMA50: $71.83

6-Pillar Scorecard Institutional Category Breakdown (FMC 4 – 2 NTR)

Columns: Metric · FMC · NTR
1. Valuation Multiples FMC
Forward P/E 5.5x 13.5x
Trailing P/E 4.2x 15.6x
PEG Ratio 0.46x 1.98x
EV / Revenue 1.5x 1.7x
2. Growth & Scale NTR
Revenue Growth (YoY) -80.5% +1.2%
Earnings Growth (YoY) -77.6% -37.6%
TTM Revenue (USD) $2.81B $27.4B
Market Cap $810.5M $33.8B
3. Profitability & Quality NTR
Gross Margin 17.6% 31.6%
Operating Margin -15.7% 13.0%
Net Profit Margin -151.2% 8.0%
Return on Equity (ROE) -218.9% 8.8%
4. Balance Sheet & Cash Flow FMC
Cash Generation (TTM) $296M $2.09B
Cash Flow Margin 10.5% 7.7%
Net Cash / Leverage $3.44B Net Debt $13.2B Net Debt (0.55x D/E)
Dividend Yield 6.32% 3.07%
5. Options & Positioning FMC
Options Structure Phase SURGE CONSOLIDATION
Current IV / %ile 104.3% (100th %ile) 38.2% (28th %ile)
Put/Call OI Skew 0.82x (Call-Skewed) 0.22x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markdown DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat FMC
OpEx & R&D Intensity 33.3% of Rev ($937M) 18.6% of Rev ($5.09B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Agricultural Inputs Operator Agricultural Inputs Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: FMC (2) vs NTR (8)
Institutional Metric FMC NTR Criterion Row Edge
Market Capitalization
Scale
$810.5M $33.8B Larger Scale NTR
Trailing P/E Ratio
Valuation
4.2x 15.6x Lower Multiple FMC
Forward P/E Ratio
Valuation
5.5x 13.5x Lower Multiple FMC
Revenue Growth (YoY)
Growth
-80.5% +1.2% Higher Growth NTR
Operating Margin (TTM)
Profitability
-15.7% 13.0% Higher Margin NTR
Net Profit Margin
Profitability
-151.2% 8.0% Higher Margin NTR
Return on Equity (ROE)
Capital Efficiency
-218.9% 8.8% Higher ROE NTR
52-Week Range Position
Momentum
4% ($4–$18) 48% ($55–$85) Stronger Trend NTR
Beta / 30D Volatility
Risk Regime
0.21β · 132% Vol -0.28β · 24% Vol Lower Realized Risk NTR
Unified Institutional Score
Composite Signal
46.7 / 100 (HOLD) 52.1 / 100 (HOLD) Higher Composite NTR
Trailing 12M Revenue (USD)
Operating Scale
$2.81B $27.4B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
17.6% 31.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.46x PEG · 1.5x EV/Rev 1.98x PEG · 1.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$296M ($3.44B Net Debt) $2.09B ($13.2B Net Debt (0.55x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NTR +7.19 pp
FMC: -7.37% · NTR: -0.18%
3M Horizon NTR +52.39 pp
FMC: -54.07% · NTR: -1.68%
6M Horizon NTR +57.91 pp
FMC: -61.09% · NTR: -3.18%
1Y Horizon NTR +81.03 pp
FMC: -64.28% · NTR: +16.75%

Financial Trajectory Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant USD Revenue & Operating Margin (%)
Period FMC Revenue NTR Revenue FMC Op. Margin NTR Op. Margin Margin Leader
Q3 '25 $2.17B $24.0B -18.8% 14.6% NTR
Q4 '25 $4.33B $21.4B 18.0% 14.4% FMC
Q1 '26 $3.03B $24.2B -0.5% 8.4% NTR
Q2 '26 $3.47B $43.2B 11.8% 18.4% NTR
Q3 '26 $420M $24.3B -596.4% 12.2% NTR

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
FMC SURGE
11d in phase · OBV NEUTRAL
Current IV 104.3%
IV Percentile 100th %ile
Put/Call OI Skew 0.82x (Call-Skewed)
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact FMC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
NTR CONSOLIDATION
52d in phase · OBV DISTRIBUTION
Current IV 38.2%
IV Percentile 28th %ile
Put/Call OI Skew 0.22x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact NTR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $68.94 · IV 31.1%

NTR Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($6,894)

Compare $6,894 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 31.1% ATM IV.

5-DAY BULLISH SWING Liq B

Dec 18 $70 / $75 Bull Call Spread

Buy 1x $70C · Sell 1x $75C · 32d

Net Entry $260 Debit
T+5d @ +5% Move +$72 (+28%)
Max Risk / Buffer $260 Capped
5d Edge & Liquidity 0.6x R:R · Liq B
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq B

Dec 18 $65 / $60 Bull Put Spread

Sell 1x $65P · Buy 1x $60P · 32d

Net Entry $70 Credit
Max Credit / Yield +$70 (+16.3% RoM)
Max Risk / Buffer -6.7% Cushion ($430 Mgn)
5d Edge & Liquidity 77% PoP · Liq B
Simulate 5-Day Payoff →
ASYMMETRIC 3-LEG STRUCTURE Liq B

Dec 18 $65P / $70-$75C Seagull

Sell 1x $65P · Buy 1x $70/$75C · 32d

Net Entry $170 Debit
T+5d @ +5% Move +$140 (+11.2% RoM)
Max Risk / Buffer -5.7% Put Cushion ($1,245 Mgn)
5d Edge & Liquidity 0.6x R:R · Liq B
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
FMC Moat Profile Cyclical / Execution-Driven Positioning
Agricultural Inputs Operator
Competes within the Agricultural Inputs value chain with $810.5M market capitalization and -15.7% operating margin.
OpEx & R&D Reinvestment 33.3% of Rev ($937M)
90D Engineering Disclosures 0 Published
NTR Moat Profile Cyclical / Execution-Driven Positioning
Agricultural Inputs Operator
Competes within the Agricultural Inputs value chain with $33.8B market capitalization and 13.0% operating margin.
OpEx & R&D Reinvestment 18.6% of Rev ($5.09B)
90D Engineering Disclosures 0 Published

Investor FAQ FMC vs NTR Key Questions & Quantitative Answers

As of Nov 17, 2026, Nutrien Ltd. Common Shares (NTR) captures the overall head-to-head institutional edge over FMC Corporation (FMC) on higher Unified Composite conviction (52.1/100 HOLD vs. 46.7/100 HOLD) after splitting the core matrix 8–2 (led by Growth & Scale, Profitability & Quality), while FMC wins 4–2 across the 6-pillar growth and valuation breakdown. FMC trades at $4.96 (5.5x Forward P/E, -15.7% operating margin) versus NTR at $69.31 (13.5x Forward P/E, 13.0% operating margin). Growth vs. Quality Trade-Off: NTR earns the overall head-to-head edge with a stronger Unified Composite Score (52.1/100 HOLD vs. FMC 46.7/100 HOLD) and -0.28β · 24% Vol risk profile, whereas FMC leads top-line expansion (-80.5% YoY revenue growth, 0.46x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: FMC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.0); meanwhile NTR trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 45.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

NTR leads the Growth & Scale pillar: FMC posts -80.5% YoY revenue growth and -77.6% YoY earnings growth on $2.81B TTM revenue (17.6% gross margin, -15.7% operating margin), compared with NTR at +1.2% YoY revenue growth and -37.6% YoY earnings growth on $27.4B TTM revenue (31.6% gross margin, 13.0% operating margin). Across the 5-period historical trajectory (Q3 '25 to Q3 '26), FMC cumulative revenue shifted -80.6% while NTR shifted +1.0%. In operating R&D and SG&A reinvestment, FMC deploys 33.3% of Rev ($937M) (0 90-day corporate R&D disclosures) versus 18.6% of Rev ($5.09B) (0 disclosures) for NTR.

FMC screens cheaper on headline valuation multiples. FMC trades at 5.5x Forward P/E, 4.2x Trailing P/E, 0.46x PEG, and 1.5x EV/Revenue (10.5% FCF margin), whereas NTR trades at 13.5x Forward P/E, 15.6x Trailing P/E, 1.98x PEG, and 1.7x EV/Revenue (7.7% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against FMC (-218.9% ROE) versus NTR (8.8% ROE) capital efficiency.

In options market volatility and institutional positioning, FMC carries 104.3% implied volatility (100th %ile, Extreme (>80th %ile)), a 0.82x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (0.21β · 132% Vol realized risk). By comparison, NTR carries 38.2% implied volatility (28th %ile, Balanced (25th–60th %ile)), a 0.22x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.28β · 24% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.